Spots Global Cancer Trial Database for Intrathecal Morphine in Robot-assisted Prostatectomy

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Intrathecal Morphine in Robot-assisted Prostatectomy

Official Title: The Efficacy of Intrathecal Morphine in Patients Undergoing Robot-assisted Prostatectomy

Study ID: NCT01991275

Conditions

Prostatic Neoplasms

Interventions

The intravenous patient-controlled analgesia

The intrathecal morphine injection

Study Description

Brief Summary: This study will investigate the efficacy and safety of intrathecal morphine for the patients undergoing robot-assisted prostatectomy

Detailed Description: Prostatectomy is the treatment of choice for prostate cancer. The robot-assisted prostatectomy is becoming the most popular surgical method for prostate cancer. The small incision after robot-assisted prostatectomy is thought to reduce the postoperative pain. There is few investigations for the strategy to reduce the postoperative pain of robot-assisted prostatectomy. The intrathecal morphine injection is known to reduce postoperative pain for surgeries like hepatectomy, myomectomy and open prostatectomy. This method, however, is not yet studied for the robot-assisted prostatectomy. This study will investigate the efficacy and safety of intrathecal morphine for the patients undergoing robot-assisted prostatectomy.